Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study
Introduction Cervical cancer screening ceases between the ages of 60 and 65 in most countries. Yet, a relatively high proportion of cervical cancers are diagnosed in women above the screening age. This study will evaluate if screening of women aged 65–69 years may result in increased detection of ce...
Saved in:
| Main Authors: | Anne Hammer, Berit Andersen, Jørgen Skov Jensen, Mette Tranberg, Lone Kjeld Petersen, Klara Miriam Elfström, Jan Blaakær, Mary Holten Bennetsen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-11-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/10/11/e039636.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nationwide cervical precancer screening in Ghana: concurrent HPV DNA testing and visual inspection under an expanded hub-and-spoke model
by: Kofi Effah, et al.
Published: (2025-01-01) -
Performance of HPV E4 and p16INK4a biomarkers in predicting regression of cervical intraepithelial neoplasia grade 2 (CIN2): protocol for a historical cohort study
by: David Jenkins, et al.
Published: (2022-07-01) -
Subjective and Objective Assessment of the Preferred Rotational Cervical Spine Position in Infants with an Upper Cervical Spine Dysfunction: A Cross-Sectional Study
by: Anke Langenfeld, et al.
Published: (2024-12-01) -
Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden.
by: Qingyun Yao, et al.
Published: (2024-12-01) -
Are the Danish stillbirth rates still record low? A nationwide ecological study
by: Lone Krebs, et al.
Published: (2020-12-01)